keyword
https://read.qxmd.com/read/36401328/automatically-detecting-crohn-s-disease-and-ulcerative-colitis-from-endoscopic-imaging
#21
JOURNAL ARTICLE
Marco Chierici, Nicolae Puica, Matteo Pozzi, Antonello Capistrano, Marcello Dorian Donzella, Antonio Colangelo, Venet Osmani, Giuseppe Jurman
BACKGROUND: The SI-CURA project (Soluzioni Innovative per la gestione del paziente e il follow up terapeutico della Colite UlceRosA) is an Italian initiative aimed at the development of artificial intelligence solutions to discriminate pathologies of different nature, including inflammatory bowel disease (IBD), namely Ulcerative Colitis (UC) and Crohn's disease (CD), based on endoscopic imaging of patients (P) and healthy controls (N). METHODS: In this study we develop a deep learning (DL) prototype to identify disease patterns through three binary classification tasks, namely (1) discriminating positive (pathological) samples from negative (healthy) samples (P vs N); (2) discrimination between Ulcerative Colitis and Crohn's Disease samples (UC vs CD) and, (3) discrimination between Ulcerative Colitis and negative (healthy) samples (UC vs N)...
November 18, 2022: BMC Medical Informatics and Decision Making
https://read.qxmd.com/read/36386153/the-novel-anti-colitic-effect-of-%C3%AE-adrenergic-receptors-via-modulation-of-ps1-bace-1-a%C3%AE-axis-and-notch-signaling-in-an-ulcerative-colitis-model
#22
JOURNAL ARTICLE
Salma Nasser, Dalaal M Abdallah, Kawkab A Ahmed, Yousra Abdel-Mottaleb, Hanan S El-Abhar
Although dysautonomia was documented in inflammatory bowel disease, with activation of the stress-related sympathetic system, the role of agonists/antagonists of the adrenergic receptors is not conclusive. Moreover, ulcerative colitis was recently linked to dementia, but the potential role of the presenilin 1(PS1)/BACE-1/beta-amyloid (Aβ) axis has not been evaluated. Hence, we investigated the impact of mirabegron (β3-agonist) and/or carvedilol (β1/β2 antagonist) on iodoacetamide-induced ulcerative colitis with emphasis on the novel pathomechanism of the PS1/BACE-1/Aβ axis in ulcerative colitis, and its relation to the inflammatory cascade, fibrotic processes, and the gut barrier dysfunction...
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/36095239/-bifidobacterium-bifidum-h3-r2-and-its-molecular-communication-within-the-context-of-ulcerative-colitis
#23
JOURNAL ARTICLE
Jiacui Shang, Shuo Yang, Zongxin Tang, Yuhan Chen, Bofan Duan, Xiangchen Meng
Bifidobacteria are important mediators of immune system development within the gastrointestinal system and immunological homeostasis. The present study explored the anti-colitic activity of Bifidobacterium bifidum H3-R2 in a murine dextran sulfate sodium (DSS)-induced model of ulcerative colitis (UC). Moreover, this study offers novel insight regarding the molecular basis for the probiotic properties of B. bifidum H3-R2 by analyzing the underlying mechanisms whereby B. bifidum H3-R2-derived proteins affect the intestinal barrier...
September 12, 2022: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/36087619/oral-exposure-to-ag-or-tio-2-nanoparticles-perturbed-gut-transcriptome-and-microbiota-in-a-mouse-model-of-ulcerative-colitis
#24
JOURNAL ARTICLE
Shuyuan Wang, Xing Kang, Harri Alenius, Sunny Hei Wong, Piia Karisola, Hani El-Nezami
Silver (nAg) and titanium dioxide (nTiO2 ) nanoparticles improve texture, flavour or anti-microbial properties of various food products and packaging materials. Despite their increased oral exposure, their potential toxicities in the dysfunctional intestine are unclear. Here, the effects of ingested nAg or nTiO2 on inflamed colon were revealed in a mouse model of chemical-induced acute ulcerative colitis. Mice (eight/group) were exposed to nAg or nTiO2 by oral gavage for 10 consecutive days. We characterized disease phenotypes, histology, and alterations in colonic transcriptome (RNA sequencing) and gut microbiome (16S sequencing)...
September 7, 2022: Food and Chemical Toxicology
https://read.qxmd.com/read/36054406/nigakinone-alleviates-dss-induced-experimental-colitis-via-regulating-bile-acid-profile-and-fxr-nlrp3-signaling-pathways
#25
JOURNAL ARTICLE
Fangle Liu, Yufeng Yao, Qian Wang, Fengxue Zhang, Meiqi Wang, Chenchen Zhu, Chaozhan Lin
The correlation of bile acid (BA) metabolism disorder with the pathogenesis of ulcerative colitis (UC) is realized nowadays. Farnesoid X receptor (FXR), a controller for BA homeostasis and inflammation, is a promising target for UC therapy. Nigakinone has potential therapeutic effects on colitis. Herein, we investigated the anti-UC effects and mechanism of nigakinone in colitic animals induced by dextran sulfate sodium (DSS). The related targets involved in the nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing 3 (NLRP3) signaling pathway were measured...
August 23, 2022: Phytotherapy Research: PTR
https://read.qxmd.com/read/36038092/dahuang-mudan-decoction-repairs-intestinal-barrier-in-chronic-colitic-mice-by-regulating-the-function-of-ilc3
#26
JOURNAL ARTICLE
Shaowei Huang, Xiaojing Wang, Xueqian Xie, Yulin Su, Zengfeng Pan, Yanyang Li, Junjie Liang, Meiling Zhang, Simin Pan, Bo Xu, Linzhu Li, Jinyan Chen, Xia Luo, Lian Zhou
ETHNOPHARMACOLOGICAL RELEVANCE: Dahuang Mudan decoction (DMD) is a classic prescription for treating intestinal carbuncle from Zhang Zhongjing's "Essentials of the Golden Chamber" in the Han Dynasty. Recent studies also prove that DMD has a therapeutic effect on ulcerative colitis (UC), but its mechanism is still unclear. AIM OF STUDY: In this study, we aim to assess the therapeutic effect of DMD on DSS-induced chronic colitis in mice and deeply expound its underlying regulative mechanism...
August 26, 2022: Journal of Ethnopharmacology
https://read.qxmd.com/read/35910802/turmeric-derived-nanovesicles-as-novel-nanobiologics-for-targeted-therapy-of-ulcerative-colitis
#27
JOURNAL ARTICLE
Caifang Gao, Yangyang Zhou, Zhejie Chen, Hongyi Li, Yaqin Xiao, Wei Hao, Ying Zhu, Chi Teng Vong, Mohamed A Farag, Yitao Wang, Shengpeng Wang
Rationale : Ulcerative colitis (UC), a typical kind of inflammatory bowel disease (IBD), is an idiopathic chronic intestinal inflammation. Conventional therapeutic strategies mainly focus on the rebalance of pro-inflammation and anti-inflammation cytokines, whereas targeting damaged intestinal barriers, imbalanced intestinal microbiota and dysregulated mucosal immune responses in UC remain a big challenge. The objective of this study was to develop turmeric-derived nanovesicles (TNVs) for alleviation of colitis and explore the underlying mechanisms...
2022: Theranostics
https://read.qxmd.com/read/35832382/-chimonanthus-nitens-oliv-leaf-granule-ameliorates-dss-induced-acute-colitis-through-treg-cell-improvement-oxidative-stress-reduction-and-gut-microflora-modulation
#28
JOURNAL ARTICLE
Jia-Qi Huang, Si-Yi Wei, Nian Cheng, You-Bao Zhong, Fei-Hao Yu, Ming-Da Li, Duan-Yong Liu, Shan-Shan Li, Hai-Mei Zhao
The rising incidence of ulcerative colitis has become a new challenge for public health. Chimonanthus nitens Oliv. leaf granule (COG) is a natural medicine used for the treatment of respiratory diseases, which has excellent anti-inflammatory and antioxidant effects. However, the therapeutic effect of COG in ulcerative colitis (UC) has not been reported. Here, the experimental colitis was treated with dextran sodium sulfate (DSS) and COG. After treatment with high (30 g/kg), medium (15 g/kg), and low (7.5 g/kg) doses of COG for 11 consecutive days, the body weight, disease activity index (DAI) score, colon length, colon weight index, and the pathological score of mice were effectively improved...
2022: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/35758181/histological-features-of-clostridioides-difficile-colitis-in-patients-with-inflammatory-bowel-disease
#29
REVIEW
Jacob R Sweeney, Carl V Crawford, Rhonda K Yantiss
AIMS: Patients with inflammatory bowel disease (IBD) are at increased risk for Clostridioides difficile infection, although clinically important infections can be difficult to recognise. C. difficile infection does not produce pseudomembranes when it occurs in IBD patients. These individuals may also be colonised by the organism, in which case diarrhoeal symptoms are not necessarily attributed to C. difficile. We performed this study to determine whether any features distinguished C. difficile-associated colitis from an IBD flare...
September 2022: Histopathology
https://read.qxmd.com/read/35669358/tenascin-c-is-a-driver-of-inflammation-in-the-dss-model-of-colitis
#30
JOURNAL ARTICLE
James Ozanne, Brandon Shek, Louise A Stephen, Amanda Novak, Elspeth Milne, Gerry Mclachlan, Kim S Midwood, Colin Farquharson
Inflammatory Bowel Disease (IBD) is a grouping of chronic inflammatory disorders of the gut. Tenascin-C is a pro-inflammatory, extracellular matrix protein found upregulated in IBD patients and whilst a pathological driver of chronic inflammation, its precise role in the etiology of IBD is unknown. To study tenascin-C's role in colitis pathology we investigated its expression in a murine model of IBD. Wild-type (WT) or tenascin-C knockout (KO) male mice were left untreated or treated with dextran sodium sulphate (DSS) in their drinking water...
June 2022: Matrix biology plus
https://read.qxmd.com/read/35552160/effects-of-prebiotic-fructooligosaccharides-on-susceptibility-to-dextran-sodium-sulfate-induced-colitis
#31
JOURNAL ARTICLE
Brooke Kaderly, Caleb Poku, Jessica Hart, Trenton Oswald, Kristen L W Walton
Inflammatory bowel disease (IBD) is a chronic intestinal disease that includes Crohn's disease and ulcerative colitis. Previous studies have found alterations in the microbiome in IBD and in animal models of IBD, underscoring the role of the intestinal microbiota in IBD pathogenesis. Prebiotics are molecules in foods, such as fructooligosaccharides and other soluble fiber molecules, that support the growth or activity of beneficial probiotic microbes. Previous studies suggest that prebiotics can reduce symptoms in models of colitis...
May 2022: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology
https://read.qxmd.com/read/35489747/changes-in-lysophospholipid-components-in-ulcerative-colitis-and-colitis-associated-cancer
#32
JOURNAL ARTICLE
Hirofumi Sonoda, Chieko Kitamura, Kuniyuki Kano, Hiroyuki Anzai, Yuzo Nagai, Shinya Abe, Yuichiro Yokoyama, Hiroaki Ishii, Junko Kishikawa, Koji Murono, Shigenobu Emoto, Kazuhito Sasaki, Kazushige Kawai, Hiroaki Nozawa, Junken Aoki, Soichiro Ishihara
BACKGROUND: In recent years, it has become clear that, in addition to normal cytokines, phospholipid mediators play an important role in the development, growth, infiltration, and metastasis of cancer and in the cancer microenvironment. A phospholipid analysis method using tandem mass spectrometry (LC-MS/MS) with high detection sensitivity has enabled quantification of phospholipids, even when using a very small sample. To date, we had applied this MS technology to colorectal cancer tissue...
May 2022: Anticancer Research
https://read.qxmd.com/read/35379749/ror%C3%AE-t-expressing-pathogenic-cd4-t-cells-cause-brain-inflammation-during-chronic-colitis
#33
JOURNAL ARTICLE
Michel Edwar Mickael, Suniti Bhaumik, Ayanabha Chakraborti, Alan A Umfress, Thomas van Groen, Matthew Macaluso, John Totenhagen, Anna G Sorace, James A Bibb, David G Standaert, Rajatava Basu
Neurobehavioral disorders and brain abnormalities have been extensively reported in both Crohn's disease and ulcerative colitis patients. However, the mechanism causing neuropathological disorders in inflammatory bowel disease patients remains unknown. Studies have linked the Th17 subset of CD4+ T cells to brain diseases associated with neuroinflammation and cognitive impairment, including multiple sclerosis, ischemic brain injury, and Alzheimer's disease. To better understand how CD4+ T lymphocytes contribute to brain pathology in chronic intestinal inflammation, we investigated the development of brain inflammation in the T cell transfer model of chronic colitis...
April 15, 2022: Journal of Immunology
https://read.qxmd.com/read/35320477/anticolitic-activity-of-prodigiosin-loaded-with-selenium-nanoparticles-on-acetic-acid-induced-colitis-in-rats
#34
JOURNAL ARTICLE
Rami B Kassab, Mohamad Elbaz, Atif A A Oyouni, Ahmad H Mufti, Abdulrahman Theyab, Ashraf Al-Brakati, Hala A Mohamed, Ali M S Hebishy, Mohammed I Y Elmallah, Mohamed S Abdelfattah, Ahmed E Abdel Moneim
Ulcerative colitis (UC) is a chronic autoimmune inflammatory disease associated with extensive mucosal damage. Prodigiosins (PGs) are natural bacterial pigments with well-known antioxidant and immunosuppressive properties. In the current study, we examined the possible protective effect of PGs loaded with selenium nanoparticles (PGs-SeNPs) against acetic acid (AcOH)-induced UC in rats. Thirty-five rats were separated into five equal groups with seven animals/group: control, UC, PGs (300 mg/kg), sodium selenite (Na2 SeO3 , 2 mg/kg), PGs-SeNPs (0...
August 2022: Environmental Science and Pollution Research International
https://read.qxmd.com/read/35314195/capsaicin-inhibits-intestinal-cl-secretion-and-promotes-na-absorption-by-blocking-trpv4-channels-in-healthy-and-colitic-mice
#35
JOURNAL ARTICLE
Hanxing Wan, Xiong Ying Chen, Fenglian Zhang, Jun Chen, Fenglan Chu, Zachary M Sellers, Feng Xu, Hui Dong
Although capsaicin has been studied extensively as an activator of the transient receptor potential vanilloid cation channel subtype 1 (TRPV1) channels in sensory neurons, little is known about its TRPV1-independent actions in gastrointestinal health and disease. Here, we aimed to investigate the pharmacological actions of capsaicin as a food additive and medication on intestinal ion transporters in mouse models of ulcerative colitis (UC). The short-circuit current (Isc ) of the intestine from WT, TRPV1-, and TRPV4-KO mice were measured in Ussing chambers, and Ca2+ imaging was performed on small intestinal epithelial cells...
May 2022: Journal of Biological Chemistry
https://read.qxmd.com/read/35058349/pharmacokinetics-and-safety-studies-in-rodent-models-support-development-of-epicertin-as-a-novel-topical-wound-healing-biologic-for-ulcerative-colitis
#36
JOURNAL ARTICLE
Daniel Tusé, Micaela Reeves, Joshua Royal, Krystal T Hamorsky, Hanna Ng, Maria Arolfo, Carol Green, Abhishek Trigunaite, Toufan Parman, Goo Lee, Nobuyuki Matoba
The novel wound-healing biologic EPICERTIN, a recombinant analog of cholera toxin B subunit, is in early development for the management of ulcerative colitis. This study established for the first time the pharmacokinetics (PK), bioavailability (BA), and acute safety of EPICERTIN in healthy and dextran sodium sulfate-induced colitic mice and healthy rats. For PK and BA assessments, single administrations of various concentrations of EPICERTIN were given intravenously or intrarectally to healthy and colitic C57BL/6 mice and to healthy Sprague-Dawley rats...
March 2022: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/35052642/nutritional-regimes-enriched-with-antioxidants-as-an-efficient-adjuvant-for-ibd-patients-under-infliximab-administration-a-pilot-study
#37
JOURNAL ARTICLE
Marina Liso, Annamaria Sila, Giulio Verna, Aurelia Scarano, Rossella Donghia, Fabio Castellana, Elisabetta Cavalcanti, Pasqua Letizia Pesole, Eduardo Maria Sommella, Antonio Lippolis, Raffaele Armentano, Anna Maria Giudetti, Daniele Vergara, Pietro Campiglia, Rodolfo Sardone, Margherita Curlo, Mauro Mastronardi, Katia Petroni, Chiara Tonelli, Angelo Santino, Marcello Chieppa
Antioxidants are privileged candidates for the development of adjuvants able to improve the efficiency of pharmacological therapies, particularly for chronic inflammatory syndromes. During the last 20 years, anti-TNFα (tumor necrosis factor alpha) monoclonal antibodies infusion has been the biological therapy most frequently administered but there is still large space for improvement in disease remission rates and maintenance. In this context, nutritional bioactive compounds contained in dietary patterns or included as supplements, may act as adjuvants for the induction and maintenance of IBD (inflammatory bowel diseases) remission...
January 8, 2022: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/35046295/-a-case-of-colitic-cancer-with-a-total-proctocolectomy-in-the-second-term
#38
JOURNAL ARTICLE
Masatoshi Yoshizawa, Masahiro Amano, Shintaro Hirata, Ryo Ishizawa, Akina Kuwahara, Satoaki Kimura, Shinichiro Usuki, Norihito Hosoi, Yukinobu Syuto, Kunihisa Miyazaki, Tomonari Amano, Miki Yoshida
The patient was 70-years-old women, 27 years ago, she was diagnosed with total colitis-type ulcerative colitis. Eighteen years after the diagnosis, she self-suspended his hospital visit because her condition was stable. After 4 years, ulcerative colitis rekindled, she resumed taking a 5-ASA. And 2 years later, colonoscopy revealed type 3 tumor in the descending colon. Tumor biopsy indicated an adenocarcinoma(tub1, tub2)derived from ulcerative colitis. Originally total proctocolectomy is necessary, but patient strongly hoped to leave the colon...
December 2021: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/34633750/role-of-gut-microbiota-in-the-anti-colitic-effects-of-anthocyanin-containing-potatoes
#39
JOURNAL ARTICLE
Shiyu Li, Tianmin Wang, Wenyi Fu, Mary Kennett, Abigail D Cox, Dale Lee, Jairam K P Vanamala, Lavanya Reddivari
SCOPE: Anthocyanin-containing potatoes exert anti-inflammatory activity in colitic mice. Gut bacterial dysbiosis plays a critical role in ulcerative colitis. This study examined the extent to which the anti-colitic activity of anthocyanin-containing red/purple-fleshed potatoes depends on the gut bacteria using a chemically-induced rodent model of colitis with the intact and antibiotic-ablated microbiome. METHODS AND RESULTS: Four-week-old male mice (C57BL6) are randomly assigned to the control diet or 20% purple-/red-fleshed potatoes supplemented diet group...
December 2021: Molecular Nutrition & Food Research
https://read.qxmd.com/read/34403100/the-potential-immunomodulatory-properties-of-levornidazole-contribute-to-improvement-in-experimental-ulcerative-colitis
#40
JOURNAL ARTICLE
Xing-Qi Wang, Hao Chen, Yu-Zhi Gao, Yan-Xiu Huang, Rui-Juan Zhang, Jun Xie, Yu Li, Yu-Qing Huang, Ling-Shan Gou, Rui-Qin Yao
The use of an antibiotic with immunomodulatory properties could be fascinating in treating multifactorial inflammatory conditions such as ulcerative colitis (UC). We report our investigations into the immunomodulatory properties of levornidazole, the S-enantiomer of ornidazole, which displayed a tremendous therapeutic potential in UC induced by dextran sodium sulfate (DSS). Levornidazole administration to DSS-colitic mice attenuated the intestinal inflammatory process, with an efficacy better than that shown by 5-amino salicylic acid...
August 2021: Current Medical Science
keyword
keyword
171562
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.